177314<\/a>, work is already underway to accelerate the roll-out of electronic prescribing and medicines administration systems across the National Health Service in England. Capital funding of £75 million over three years has been allocated to support this roll-out, with £16 million available in 2018/19.<\/p> <\/p>
Trusts were invited to submit bids to be included in wave 1 of the roll-out in July 2018, and the 13 successful applicants were informed at the beginning of October 2018.<\/p>
<\/p>
Further bids will be invited for wave 2 funding early next year for award in the subsequent financial year.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-13T11:41:46.167Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Prescriptions: ICT"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 October 2018 to Question 177314 on Prescriptions: ICT, what recent steps he has taken to accelerate the roll-out of electronic prescribing medications systems.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "188104"}
, {"_about" : "http://data.parliament.uk/resources/1001902", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1001902/answer", "answerText" : {"_value" : "
No such cost analysis has been performed.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-13T11:47:30.607Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential cost savings to the NHS of making automated medicines cabinets mandatory in every NHS trust.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "188105"}
, {"_about" : "http://data.parliament.uk/resources/1001903", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1001903/answer", "answerText" : {"_value" : "
The Department works with NHS Improvement, NHS England, the Medicines and Healthcare products Regulatory Agency (MHRA), Public Health England, and the Medication Safety Officer Network to improve the safety of medicine use across the National Health Service in England.<\/p>
<\/p>
The Medication Safety Programme, covering the NHS in England, has been established to take up the World Health Organization\u2019s (WHO) global challenge to reduce the incidence of severe and avoidable harm in relation to medication globally by 50% over five years. Progress to date includes the publication of the Short Life Working Group into Reducing Medication Harm and the publication of an evidence-based review on the Prevalence and Economic Burden of Medication Errors in the NHS in England, which has helped the programme to understand the scale of the issue and identify key areas for improvement.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-13T11:43:41.843Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce the number of medication errors that result in serious harm to patients; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "188106"}
, {"_about" : "http://data.parliament.uk/resources/1001904", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1001904/answer", "answerText" : {"_value" : "
The Department commissioned a study by the Policy Research Unit in Economic Evaluation of Health and Care Interventions on the prevalence and economic burden on medication errors in the National Health Service in England. Prevalence and Economic Burden of Medication Errors in the NHS in England was published in February 2018.<\/p>
<\/p>
This study estimated a range of costs to the NHS depending on which costs are included in the analysis. The range is from a baseline of £98.5 million per annum. The highest cost scenario has estimated costs to the NHS of £1.6 billion.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-13T11:42:40.243Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of how much medication errors have cost the NHS in each year for which information is available; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "188107"}
, {"_about" : "http://data.parliament.uk/resources/1001905", "AnsweringBody" : [{"_value" : "Department for Exiting the European Union "}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1001905/answer", "answerText" : {"_value" : "
As set out in the White Paper the UK proposes a UK-EU free trade area for goods, to ensure continued frictionless access at the border to each other\u2019s markets, with no tariffs, underpinned by an upfront commitment to a common rulebook on goods, including agri-food and a Facilitated Customs Arrangement to avoid customs checks and controls at our borders.<\/p>
However, in the unlikely event of a no deal scenario, trade with the EU will be on non-preferential, WTO terms. This means that most favoured nation (MFN) tariffs would apply to consignments between the UK and EU.<\/p>
The EU MFN rates are set out in the EU's Common Customs Tariff (CCT). The EU may change these rates between now and March 2019, but this provides an indication.<\/p>
The UK will apply its MFN rates to goods imported into the UK from the EU. The government will determine and publish these new UK duty rates before we leave the EU. They may be different from the rates in the EU\u2019s CCT.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3977", "label" : {"_value" : "Biography information for Chris Heaton-Harris"}
}
, "answeringMemberConstituency" : {"_value" : "Daventry"}
, "answeringMemberPrinted" : {"_value" : "Chris Heaton-Harris"}
, "dateOfAnswer" : {"_value" : "2018-11-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-15T15:01:36.177Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "203"}
, "answeringDeptShortName" : {"_value" : "Exiting the European Union "}
, "answeringDeptSortName" : {"_value" : "Exiting the European Union "}
, "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cars: Export Duties"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Exiting the European Union, what the tariff at World Trade Organisation rates would be on exporting a car made in the UK to the EU and (a) valued at £15,000 at the point of export and (b) valued at £25,000 at the point of export in the event of the UK leaving the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "188108"}
, {"_about" : "http://data.parliament.uk/resources/1001906", "AnsweringBody" : [{"_value" : "Cabinet Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1001906/answer", "answerText" : {"_value" : "
I have nothing further to add to my Answer of 11 October to Question 175797.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/15", "label" : {"_value" : "Biography information for Sir David Lidington"}
}
, "answeringMemberConstituency" : {"_value" : "Aylesbury"}
, "answeringMemberPrinted" : {"_value" : "Mr David Lidington"}
, "dateOfAnswer" : {"_value" : "2018-11-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-12T17:27:26.563Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "53"}
, "answeringDeptShortName" : {"_value" : "Cabinet Office"}
, "answeringDeptSortName" : {"_value" : "Cabinet Office"}
, "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Intelligence Services: Detainees"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Minister for the Cabinet Office, pursuant to the Answer of 11 October to Question 175797, what the timeframe for its response to the Intelligence and Security Committee's reports on detainee mistreatment and rendition is.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"}
}
, "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"}
, "tablingMemberPrinted" : [{"_value" : "Tom Brake"}
], "uin" : "187980"}
, {"_about" : "http://data.parliament.uk/resources/1001907", "AnsweringBody" : [{"_value" : "Northern Ireland Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1001907/answer", "answerText" : {"_value" : "
This is a devolved issue. Northern Ireland Office officials have been liaising with the Northern Ireland Department of Health on this important issue and I am pleased to hear that work is ongoing to ensure an appropriate process is in place which will provide clinical consultants, and hence patients, access as soon as possible.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1496", "label" : {"_value" : "Biography information for Shailesh Vara"}
}
, "answeringMemberConstituency" : {"_value" : "North West Cambridgeshire"}
, "answeringMemberPrinted" : {"_value" : "Mr Shailesh Vara"}
, "dateOfAnswer" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-13T15:48:42.6Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "21"}
, "answeringDeptShortName" : {"_value" : "Northern Ireland"}
, "answeringDeptSortName" : {"_value" : "Northern Ireland"}
, "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Northern Ireland"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Northern Ireland, with reference to the Department of Health in Northern Ireland (DHNI)\u2019s press release entitled Department Announces Improved Access to New Drugs, published on 12 September 2018, what discussions she has had with the DHNI on the timeline for providing access to medicines approved for use through the Cancer Drug Fund in England; and if she will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "188109"}
, {"_about" : "http://data.parliament.uk/resources/1001908", "AnsweringBody" : [{"_value" : "Ministry of Housing, Communities and Local Government"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1001908/answer", "answerText" : {"_value" : "
Last year the Government\u2019s Clean Growth Strategy, which supports the Industrial Strategy, announced a Local Energy Programme, which supports local actors, community groups, local authorities and combined authorities to develop their own energy strategies and deliver their own energy programmes. Community energy is a key part of clean growth, showing what can happen when groups of people come together to de-carbonise energy in local areas, whilst also investing in these places to bring other economic, or social, benefits. Even small-scale projects can provide a valuable contribution to cutting greenhouse gas emissions.<\/p>
The National Planning Policy Framework expects local planning authorities to recognise the responsibility on all communities to contribute to energy generation from renewable or low carbon sources. New tests were introduced into planning in 2015 to give local people the final say on onshore wind planning applications in England, which delivered on a manifesto commitment made by the previous Government. Planning for onshore wind turbines in the UK is devolved outside of England.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4495", "label" : {"_value" : "Biography information for Kit Malthouse"}
}
, "answeringMemberConstituency" : {"_value" : "North West Hampshire"}
, "answeringMemberPrinted" : {"_value" : "Kit Malthouse"}
, "dateOfAnswer" : {"_value" : "2018-11-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-12T17:16:51.493Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "7"}
, "answeringDeptShortName" : {"_value" : "Housing, Communities and Local Government"}
, "answeringDeptSortName" : {"_value" : "Housing, Communities and Local Government"}
, "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Wind Power: Planning Permission"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Housing, Communities and Local Government, what scientific research underpins the Government's current policy on the granting of planning permission for onshore wind farms, particularly community-owned onshore wind turbines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4662", "label" : {"_value" : "Biography information for Ruth George"}
}
, "tablingMemberConstituency" : {"_value" : "High Peak"}
, "tablingMemberPrinted" : [{"_value" : "Ruth George"}
], "uin" : "188231"}
, {"_about" : "http://data.parliament.uk/resources/1001909", "AnsweringBody" : [{"_value" : "Department for Transport"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1001909/answer", "answerText" : {"_value" : "
Funding to local authorities for concessionary travel is not provided in isolation, but as part of their Local Government Finance Settlement. This Formula Grant funding is not ring-fenced, which enables authorities to make spending decisions that more closely match local needs and circumstances.<\/p>
<\/p>
Eligibility for the statutory concession on medical grounds is assessed by local authorities on a case by case basis, using the seven criteria set down in legislation and supported by the Department\u2019s published guidance.<\/p>
Local authorities also have the powers to offer concessions over and above the statutory minimum, for instance by extending the concession to residents who may not qualify under the statutory criteria.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4460", "label" : {"_value" : "Biography information for Ms Nusrat Ghani"}
}
, "answeringMemberConstituency" : {"_value" : "Wealden"}
, "answeringMemberPrinted" : {"_value" : "Ms Nusrat Ghani"}
, "dateOfAnswer" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-13T14:39:39.24Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "27"}
, "answeringDeptShortName" : {"_value" : "Transport"}
, "answeringDeptSortName" : {"_value" : "Transport"}
, "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Bus Services: Concessions"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Transport, what research his Department has undertaken on the effect of recent reductions to funding for concessionary bus passes on adults with (a) learning difficulties and (b) autism.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol West"}
, "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"}
], "uin" : "188110"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&max-ddpCreated=2018-11-05T22%3A17%3A18.117Z&AnswerDate=2018-11-12", "page" : 0, "startIndex" : 1, "totalResults" : 137, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}